Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Allergan
Latest Articles
Actavis's Brent Saunders Is Pharma's Best-Looking CEO
Editors
March 12, 2015
Actavis CEO Brent Saunders Has a Vision for Growth
Anne Szustek
Allergan-Pfizer Merger Gives Pharma a Growth Injection
Anne Szustek
Daily Agenda: Commodity Rout Continues
Andrew Barber
Daily Agenda: Gravity Returns to Chinese Stock Market
Andrew Barber
Daily Agenda: Liquidity Fuels Continuing M&A Boom
Andrew Barber
David Pyott
David Pyott of Allergan: Eyes on the Prize
Justin Schack
Deals of the Year 2014: Actavis Realizes Bigger Pharma Ambitions
Anne Szustek
Golden Parachutes Leave Investors Fearing Conflict of Interest
Jeff Ostrowski
Inbound M&A Adds Fuel to a Hot Deal Market
Dan Weil
Premium
Inside the Trade: What Bill Ackman Sees in Valeant and Allergan
Michael Peltz
Premium
Jana Partners Continues As It Finished the Year: Down
Stephen Taub
Premium
Jana Records a Slightly Down March as Volatilty Hits
Stephen Taub
Minding the Gap Between GAAP, Pro Forma Earnings
Dan Weil
Perella Weinberg’s Andrew Bednar Drives Stock Exchange Megadeals
David Rothnie
Premium
The 2015 Rich List: The Highest Earning Hedge Fund Managers of the Past Year
Stephen Taub
Premium
The 50 Stocks That Hedge Fund Managers Like Best
Stephen Taub
More Articles